Pharmacokinetic and Safety Study of Cenicriviroc and HMG-CoA Reductase Inhibitors, Caffeine and Digoxin
Clinical trial NCT02685462 · COMPLETED
Trial details
- NCT number
- NCT02685462
- Sponsor
- Tobira Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-31
- Primary completion
- 2016-02-23
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.